68 Results for "

cell-based assay

" in MedChemExpress (MCE) Product Catalog:
Products (68)

68 Results for "cell-based assay" in MCE Product Catalog:

Cat. No.: HY-163343
CAS No.: 3029600-37-8
Research Areas:  

Cancer

Enpp-1-IN-20 (Compound 31) is an ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) inhibitor, with an IC50 of 0.09 nM. Enpp-1-IN-20 has strongest inhibitory activity in the cell-based assay, with an IC50 of 8.8 nM. Enpp-1-IN-20 has significant potency in both ENPP1 inhibition and STING pathway stimulation in vitro. Enpp-1-IN-20 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-103608
CAS No.: 1835705-61-7
Purity:  99.89%
Synonyms: VHL Ligand-Linker Conjugates 11; E3 ligase Ligand-Linker Conjugates 11
Research Areas:  

Cancer

(S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl is a small molecule HaloPROTAC that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker. (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays .
loading...
    loading...
Cat. No.: HY-50878S
CAS No.: 1395950-84-1
Synonyms: PF-02341066-d5
Crizotinib-d5 is the deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition .
loading...
    loading...
Cat. No.: HY-103606
CAS No.: 1835705-59-3
Purity:  96.24%
Synonyms: VH032-PEG6-C4-Cl; VHL Ligand-Linker Conjugates 10; E3 ligase Ligand-Linker Conjugates 9
Research Areas:  

Cancer

(S,R,S)-AHPC-PEG6-C4-Cl is a conjugate of ligands for E3 and 25-atom-length linker. The connector of linker is Halogen group. (S,R,S)-AHPC-PEG6-C4-Cl incorporates the (S,R,S)-AHPC based VHL ligand and 6-unit PEG linker. (S,R,S)-AHPC-PEG6-C4-Cl is capable of inducing the degradation of GFP-HaloTag7 in cell-based assays .
loading...
    loading...
Cat. No.: HY-G0002
CAS No.: 186204-33-1
Lurasidone metabolite 14326 is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 can be used in the research of schizophrenia and bipolar depression .
loading...
    loading...
Cat. No.: HY-177617
CAS No.: 1378549-07-5
Synonyms: IMO-8400
Research Areas:  

Inflammation/Immunology

Bazlitoran (IMO-8400) is an oligonucleotide-based TLR7/8/9 antagonist. Bazlitoran blocks the activation of Toll-like receptors 7, 8, and 9. Bazlitoran inhibits cytokine responses mediated by Toll-like receptors 7, 8, and 9. Bazlitoran is associated with injection site reactions. Bazlitoran improves moderate-to-severe plaque psoriasis .
loading...
    loading...
Cat. No.: HY-112437
CAS No.: 1863905-38-7
Purity:  99.70%
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

PF-06737007 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 7.7 nM, 15 nM and 3.9 nM for TrkA, TrkB and TrkC, respectively . Anti-hyperalgesic effect .
loading...
    loading...
Cat. No.: HY-G0002A
Lurasidone metabolite 14326 hydrochloride is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 hydrochloride shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 hydrochloride can be used in the research of schizophrenia and bipolar depression .
loading...
    loading...
Cat. No.: HY-175250
Target:  

TNF Receptor

Research Areas:  

Inflammation/Immunology

TNF-α-IN-25 is an orally active TNF-α inhibitor. TNF-α-IN-25 shows Fluorescence Polarization (FP) assay IC50 of 103 nM in FP binding assays and L929 assay IC50 of 505 nM in cell-based assays. TNF-α-IN-25 inhibits paw swelling in the glucose-6-phosphate isomerase (GPI) arthritis model. TNF-α-IN-25 can be used for the study of arthritis .
loading...
    loading...
Cat. No.: HY-161352
CAS No.: 1429218-68-7
Target:  

Virus Protease

Research Areas:  

Infection

NPI52 (Compound E1) is a foot-and-mouth disease virus 3C protease (FMDV 3Cpro) inhibitor, with IC50 values of 0.05 and 0.11 µM in FRET and cell-based assay, respectively .
loading...
    loading...
Cat. No.: HY-134811
CAS No.: 2621928-43-4
Purity:  98.45%
Target:  

Ras PERK

Research Areas:  

Cancer

KRAS G12D inhibitor 1 is a KRAS G12D inhibitor with an IC50 value of 0.4 nM. KRAS G12D inhibitor 1 inhibits KRas G12D-mediated ERK phosphorylation. KRAS G12D inhibitor 1 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-105253
CAS No.: 912444-01-0
Target:  

PARP

Research Areas:  

Neurological Disease

PARP-2/1-IN-2 (Compound 4a), the enantiomer of Veliparib (HY-10129), is a potent PARP inhibitor with Kis of 2 and 5 nM against PARP-2 and PARP-1, respectively. PARP-2/1-IN-2 has an EC50 of 3 nM in a cell based assay of PARP activity .
loading...
    loading...
Cat. No.: HY-10237R
CAS No.: 394730-60-0
Synonyms: EBP 520 (Standard); SCH 503034 (Standard)
Research Areas:  

Infection

Boceprevir (Standard) is the analytical standard of Boceprevir. This product is intended for research and analytical applications. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay . Boceprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
Cat. No.: HY-50878AS
Synonyms: PF-02341066-d9 hydrochloride
Crizotinib-d9 hydrochloride is deuterated labeled Crizotinib hydrochloride (HY-50878A). Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition .
loading...
    loading...
Cat. No.: HY-177123
CAS No.: 2922808-66-8
Target:  

Complement System

Research Areas:  

Inflammation/Immunology

Refinicopan is a complement factor D inhibitor with an IC50 of 10 nM. Refinicopan inhibits hemolysis of rabbit red blood cells. Refinicopan can be used to study diseases mediated by complement factor D .
loading...
    loading...
Cat. No.: HY-179180
CAS No.: 2891831-40-4
Target:  

PD-1/PD-L1

Research Areas:  

Cancer

PD-1/PD-L1-IN-59 (Compound MZ51) is a PD-1/PD-L1 inhibitor with an IC50 of 183 nM. PD-1/PD-L1-IN-59 can be used for the study of triple-negative breast cancer (TNBC) .
loading...
    loading...
Cat. No.: HY-163520
Research Areas:  

Others

IDO1-IN-24 (compound 2c) inhibits IDO1 production in cell-based assay with an IC50 value of 17 μM .
loading...
    loading...
Cat. No.: HY-112434
CAS No.: 1873373-33-1
Target:  

Trk Receptor

Research Areas:  

Neurological Disease

PF-06733804 is a potent pan-Trk inhibitor in cell-based assays with IC50s of 8.4 nM, 6.2 nM and 2.2 nM for TrkA, TrkB and TrkC, respectively . Anti-hyperalgesic effect .
loading...
    loading...
Cat. No.: HY-10555
CAS No.: 1095565-81-3
Target:  

11β-HSD

Research Areas:  

Metabolic Disease

AMG-221 is an inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) with a Ki of 12.8 nM in vitro biochemical scintillation proximity assay (SPA) and an IC50 of 10.1 nM in cell-based assays . AMG-221 can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-10237S
CAS No.: 1256751-11-7
Synonyms: EBP 520-d9; SCH 503034-d9
Boceprevir-d9 is the deuterium labeled Boceprevir. Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay . Boceprevir inhibits SARS-CoV-2 3CLpro activity .
loading...
    loading...